Although, anecdotally, it is no secret that Mounjaro is already being prescribed to patients without T2D for weight loss and the comorbidity of T2D and obesity blurs the line, once Mounjaro is approved I believe it will begin reducing the average out of pocket costs for these drugs
Scientists compared data from two groups of women: those with diabetes, obesity, or both who were taking a GLP-1, and women with the same conditions who were taking some other type of diabetes medication
Keep reading Published on: February 22, 2024 Overcoming obstacles: How one health system is creating a more inclusive health care future Republished Content: Atlanta Business Chronicle This article was originally published on Atlanta Business Chronicle on January 6, 2024
There is, however, a class of medications known as GLP-1 agonists, which a medical professional may consider in the treatment of diagnosable diseases such as Type 2 diabetes
& Meier, J
For more insight into how our research team vets, qualifies, and ranks providers, review our full methodology here
